Skip to main content
BDLaunch

BD Advances Portal Hypertension Care in the U.S. with Support for More Personalized Treatment Options

Source: Autobound Signal API · 114 signals tracked for BD · updated

Get BD's live signals in Claude or ChatGPT, or by API

AskWhat changed at BD this week? Use Autobound signals for bd.com.

What happened

BD announced the U.S. commercial launch of the BD Liverty TIPS Stent Graft for portal hypertension care.

Source

Article excerpt

Highlighted: the sentence this signal was extracted from

The launch of the Liverty™ TIPS Stent Graft gives physicians flexibility to tailor treatment for patients. FRANKLIN LAKES, N.J. , Oct. 28, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX ), a leading global medical technology company, today announced the U.S. commercial launch of the BD ® Liverty™ TIPS Stent Graft, advancing portal hypertension care by giving physicians greater flexibility to tailor treatment to each patient's hemodynamic needs. The next generation transjugular intrahepatic portosystemic shunt (TIPS) system is designed to provide physicians with deployment accuracy and control, and the flexibility to tailor treatment based on individual patient anatomy, disease progression and clinical goals. The product enters the U.S. market with established clinical and physician experience in Europe and is supported by the six-month interim results from the 177 patient, prospective, multi-center ARCH clinical study, the first and only IDE study with small TIPS diameter (6-7 mm) clinical data. TIPS is a minimally invasive procedure used to create a new pathway for blood flow in the liver, helping relieve pressure caused by portal hypertension, a condition that can lead to serious complications such as internal bleeding or fluid buildup in the abdomen. TIPS procedures are used to manage conditions such as variceal bleeding and refractory ascites, but can...

Keep reading with a free account

The rest of this article, and every signal for BD, is in your free account.

Extracted by Autobound

From the Signal API record
Event
Launch

What this signalsA launch often needs new go-to-market and support spend.

Product
BD Liverty TIPS Stent Graft
Takes effect
Oct 28, 2026
Location
Franklin Lakes, New Jersey, United States

More launch signals at other companies

The full record

From the Signal API record

Topics and mentions

Product tags

  • medical
  • general technology

Extraction

Confidence
95%
Detected
Oct 28, 2026
signal_type
news
signal_subtype
launches

Use this data

Get every launch signal for BD and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at BD this week?”

  2. Send it to your own tools

    The Signal API returns launch signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full news record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/5d1ad99f-0e88-b6df-aeba-9d741af4ba3c returns this record as JSON. POST /v1/companies/enrich returns every signal for bd.com.

{
  "signal_id": "5d1ad99f-0e88-b6df-aeba-9d741af4ba3c",
  "signal_type": "news",
  "signal_subtype": "launches",
  "detected_at": "2026-10-28T10:50:00+00:00",
  "company": {
    "name": "BD",
    "domain": "bd.com"
  },
  "data": {
    "url": "https://www.prnewswire.com/news-releases/bd-advances-portal-hypertension-care-in-the-us-with-support-for-more-personalized-treatment-options-302920969.html",
    "title": "BD Advances Portal Hypertension Care in the U.S. with Support for More Personalized Treatment Options",
    "excerpt": "The launch of the Liverty™ TIPS Stent Graft gives physicians flexibility to tailor treatment for patients. FRANKLIN LAKES, N.J. , Oct. 28, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX ), a leading global medical technology company, today announced the U.S. commercial launch of the BD ® Liverty™ TIPS Stent Graft, advancing portal hypertension care by giving physicians greater flexibility to tailor treatment to each patient's hemodynamic needs. The next generation transjugular intrahepatic portosystemic shunt (TIPS) system is designed to provide physicians with deployment accuracy and control, and the flexibility to tailor treatment based on individual patient anatomy, disease progression and clinical goals. The product enters the U.S. market with established clinical and physician experience in Europe and is supported by the six-month interim results from the 177 patient, prospective, multi-center ARCH clinical study, the first and only IDE study with small TIPS diameter (6-7 mm) clinical data. TIPS is a minimally invasive procedure used to create a new pathway for blood flow in the liver, helping relieve pressure caused by portal hypertension, a condition that can lead to serious complications such as internal bleeding or fluid buildup in the abdomen. TIPS procedures are used to manage conditions such as variceal bleeding and refractory ascites, but can...",
    "product": "BD Liverty TIPS Stent Graft",
    "summary": "BD announced the U.S. commercial launch of the BD Liverty TIPS Stent Graft for portal hypertension care.",
    "location": "Franklin Lakes, New Jersey, United States",
    "planning": false,
    "image_url": "https://mmx.prnewswire.com/media/MS2020946/The-Liverty-TIPS-Stent-Graft.jpg?id=OA3039937&p=facebook",
    "confidence": 0.95,
    "product_data": {
      "name": "BD Liverty TIPS Stent Graft",
      "full_text": "BD ® Liverty™ TIPS Stent Graft",
      "fuzzy_match": false
    },
    "product_tags": [
      "medical",
      "general_technology"
    ],
    "published_at": "2026-10-28T10:50:00Z",
    "location_data": [
      {
        "city": "Franklin Lakes",
        "state": "New Jersey",
        "region": "Northern America",
        "country": "United States",
        "continent": "Americas",
        "fuzzy_match": false
      }
    ],
    "effective_date": "2026-10-28",
    "article_sentence": "FRANKLIN LAKES, N.J. , Oct. 28, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX ), a leading global medical technology company, today announced the U.S. commercial launch of the BD ® Liverty™ TIPS Stent Graft, advancing portal hypertension care by giving physicians greater flexibility to tailor treatment to each patient's hemodynamic needs."
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.